<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SOFHF7YZ/d5a6a3f9-e3f6-45ac-a375-801abb36cb97/PDF"><dcterms:extent>2637 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SOFHF7YZ/cf957e8d-b6db-40f3-b6fa-00423efd06b1/TEXT"><dcterms:extent>13 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-SOFHF7YZ"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:SPR-WQVGMCSC" /><dcterms:issued>1998</dcterms:issued><dc:creator>Dragoš, Vlasta</dc:creator><dc:creator>Zaletel-Kragelj, Lijana</dc:creator><dc:format xml:lang="sl">številka:3/4</dc:format><dc:format xml:lang="sl">letnik:7</dc:format><dc:format xml:lang="sl">str. 167-170</dc:format><dc:identifier>ISSN:1318-4458</dc:identifier><dc:identifier>COBISSID:8098009</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-SOFHF7YZ</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovene Welding Society</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta dermatovenerologica Alpina, Pannonica et Adriatica</dcterms:isPartOf><dc:subject xml:lang="sl">Allylamine</dc:subject><dc:subject xml:lang="sl">Analysis</dc:subject><dc:subject xml:lang="sl">Child</dc:subject><dc:subject xml:lang="sl">dermatologija</dc:subject><dc:subject xml:lang="sl">Drug therapy</dc:subject><dc:subject xml:lang="sl">Hair</dc:subject><dc:subject xml:lang="sl">kožne bolezni</dc:subject><dc:subject xml:lang="sl">Microsporum</dc:subject><dc:subject xml:lang="sl">mikrosporija</dc:subject><dc:subject xml:lang="sl">otroci</dc:subject><dc:subject xml:lang="sl">Tinea capitis</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Terbinafine levels in hair-samples of children with microsporum canis scalp infection|</dc:title><dc:description xml:lang="sl">Eighteen children, aged 2-11 years, with Microsporum canis scalp infection were trated with terbinafine orally for 6-16 weeks according to body weight. We studied the levels of terbinafine in the hair samples with HPLC (high-pressure liquid chromatography) at the end of treatment and again 1 and 2 weeks later. Hair samples were obtained by shaving the same area of the scalp. THe cultures were made simultaneously. The concentration of terbinafineexpressed in ng/10mg of hair weight was correlated with the result of culture (positive-negative). Eleven of 18 children had all cultures negative and the treatment was successful. The median value of terbinafine concentrations were 33ng/10mg of hair, at the end of the therapy, 378ng/10mg hair one week later, and 56ng/10mg hair two weeks later. Seven of 18 children had all cultures positive and treatment was not successful. The median values of terbinafine concentrations were 15ng/10mg of hair at the end of treatment, 5ng/10mg of hair one week later and, 7ng/10mg of hairs 2 weeks later. The concentrations of terbinafine were much higher in the group of patients, in whom the therapy was successful, although there were no differences in the age, dosage of the drug and duration of the treatment. The reasons for differences are not known and may have appeared due to lower sebum output in some patients. Microsporum canis may need much higher levels of the systemic antifugals at the site of infection for complete cure. The determination of drug levels in the target tissue and its correlation with cultures may be a useful method of evaluating the in vivo effect of systemically administered antifungals</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-SOFHF7YZ"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-SOFHF7YZ" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-SOFHF7YZ/d5a6a3f9-e3f6-45ac-a375-801abb36cb97/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Združenje slovenskih dermatovenerologov</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-SOFHF7YZ/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-SOFHF7YZ" /></ore:Aggregation></rdf:RDF>